Prevention of adverse drug reactions in older patients;Prävention unerwünschter arzneimittelwirkungen bei älteren patienten

Zeitschrift fur Gerontologie und Geriatrie

Volumn 40, Issue 4, 2007, Pages 241-254

  Burkhardt, H ^a   Wehling, M ^a   Gladisch, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adverse drug reaction; Elderly; Prevention

Indexed keywords

AGED; CAUSE OF DEATH; CHEMICALLY INDUCED DISORDER; DELIRIUM; DOSE RESPONSE; DRUG COMBINATION; DRUG INTERACTION; DRUG TOXICITY; FALLING; FEMALE; GENETICS; GERMANY; HUMAN; MALE; MORTALITY; PHARMACOEPIDEMIOLOGY; PHARMACOGENETICS; PHARMACOKINETICS; REVIEW; RISK FACTOR; STATISTICS;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DELIRIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DRUG TOXICITY; FEMALE; GERMANY; HUMANS; MALE; PHARMACOEPIDEMIOLOGY; PHARMACOGENETICS; PHARMACOKINETICS; RISK FACTORS;

EID: 36248982067     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-007-0468-9     Document Type: Review

References (95)

1. Abernethy DR, Schwartz JB, Plachetka JR, Todd EL, Egan JM (1987) Comparison in young and elderly patients of pharmacodynamics and disposition of labetolol in systemic hypertension. Am J Cardiol 60:697-702
2. Abernethy DR (2001) Drug therapy in the elderly. In: Atkinson AJ, Daniels CE, Dedrick RL, Grudzinskas CV, Markey SP, editors. Principles of Clinical Pharmacology. San Diego: Academic Press; pp 307-318
3. Adams KRH, Martin JA (1991) Electrolyte disorders in the elderly. Drugs Aging 1:254-265
4. Aronow WS (2003) Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients. Heart Dis 5:241-243
5. Aronson JK, Ferner RE (2003) Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 327:1222-1225
6. Atkin, PA, Finnegan TP, Ogle SJ, Shenfield GM (1994) Functional ability of patients to manage medication packaging. A survey of geriatric inpatients. Age Ageing 23:113-116
7. Beard K (1992) Adverse reactions as a cause of hospital admission in the aged. Drugs Aging 2:356-367
8. Beers, MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 157:1531-1536
9. Beers MH, Ouslander JG, Rollingher, I, Brooks J, Reuben D, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med 151:1825-1832
10. Beier ME, Ackerman PL (2003) Determinants of health knowledge: an investigation of age, gender, abilities, personality, and interests. J Pers Soc Psychol 84:439-448
11. Blain H, Blain A, Tréchot P, Jeandel, C (2000) Rôle des médicaments dans les chutes des sujets âgés. Presse Med 29:673-680
12. Bonow RO, Udelson JE (1992) Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Int Med 117:502-510
13. Borda IT, Slone D, Jick H (1968) Boston Collaborative Surveillance Program. Assessment of adverse reactions within a drug surveillance program. JAMA 205:645-647
14. Brennan TA, Leape LL, Laird NM, Herbert L, Localio AR, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH (1991) Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 324:370-376
15. Bugeja G, Kumar A, Banerjee AK (1997) Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 315:1059
16. Burkhardt H, Hahn T, Gretz N, Gladisch R (2005) Bedside estimation of the glomerular filtration rate in hospitalized elderly patients. Nephron Clin Pract 101:c1-c8
17. Burkhardt H, Karaminejad E, Gladisch R (2006) A short performance test can help to predict adherence to self-administration of insulin in elderly patients with diabetes. Age Ageing 35:449-452
18. Calis KA, Young LR (2001) Clinical analysis of adverse drug reactions. In: Atkinson, AJ, Daniels, CE, Dedrick, RL, Grudzinskas, CV, Markey, SP, editors. Principles of Clinical Pharmacology. San Diego: Academic Press
19. Campbell AJ (1991) Drug treatment as a cause of falls in old age. Drugs Aging 1:289-302
20. Carbonin P, Pahor M, Bernabei R, Sgadari A (1991) Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 39:1093-1099
21. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
22. Cole MG (2004) Delirium in elderly patients. Am J Geriatr Psychiatry 12:17-21
23. Cumming RG (1998) Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging 12:43-53
24. de Winter LJM, Hoyng CB, Froeling PGAM, Meulendijks CFM, van der Wilt GJ (2004) Prevalence of remediable disability due to low vision among institutionalized elderly people. Gerontology 50:96-101
25. Edwards IR, Aronson JK (2000) Advese drug reactions: definitions, diagnosis and management. Lancet 356:255-259
26. Feinberg M (1993) The problems of anticholinergic adverse effects in older patients. Drugs Aging 3:335-348
27. Ferner RE, Coleman J (2005) Anticipating, preventing and investigation medication erors. Clin Med 5:12-15
28. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean R, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 163:2716-2724
29. Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC, Auger JC, Gaber LA, Cadoret C, Fish LS, Garber LD, Kelleher M, Bates DW (2004) Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 52:1349-1354
30. Fillenbaum GG, Pieper CF, Cohen HJ, Cornoni-Huntley JC, Guralnik JM (2000) Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. J Gerontol Med Sci 55A:M84-M89
31. Fincham E (1998) Patient compliance in the ambulatory elderly: a review of the literature. Journal of Geriatric Drug Therapy 2:31-52
32. Fitzpatrick Al, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JCS, Jones B, Lyketsos C, Dulberg C (2004) Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 52:195-204
33. Flather MD, Shibata MC, Coats AJS, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA on behalf of the SENIORS investigators (2005) Randomized trial to determine the effect of nevibolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215-225
34. Fliser D, Franek E, Ritz E (1997) Renal function in the elderly - is the dogma of an inexorable decline of renal function correct? Nephrol Dial Transplant 12:1553-1555
35. Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader RI (1991) Sensitivity to triazolam in the elderly. N Engl J Med 324:1691-1698
36. Gurwitz JH, Avorn J (1991) The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 114:956-966
37. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber,L, Kelleher M, Bates DW (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289:1107-1116
38. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, Damsbo N (1990) Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 228:83-90
39. Han L, McCusker J, Cole M, Abrahamowicz M, Primeau F, Elie M (2001) Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 161:1099-1105
40. Haynes RB (1979) Introduction. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore, London: The Johns Hopkins University Press, pp 1-7
41. Helmchen H, Baltes MM, Geiselmann B, Kanowski S, Linden M, Reischies FM, Wagner M, Wernicke T, Wilms HU (2001) Psychiatric illnesses in old age. In: The Berlin Aging Study, aging from 70 to 100. Cambridge: Cambridge University Press, pp 197-226
42. Higgins N, Regan C (2004) A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 33:224-229
43. http://medicine.iupui.edu/flockhart - letzter Zugriff: 15. 5. 2007
44. http://www.meps.ahrq.gov/papers/st66/ stat66.pdf - letzter Zugriff: 15. 5. 2007
45. Inouye SK (1994) The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 97:278-287
46. Ioannidis JP, Lau J (2001) Completeness of safety reproting in randomized trials: an evaluation of 7 medical areas. JAMA 285:437-443
47. Ioannidis JPA, Evans SJW, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D, for the CONSORT Group (2004) Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141:781-788
48. Kruse WHH (1995) Comprehensive geriatric assessment and medication compliance. Z Gerontol Geriat 28:54-61
49. Landi F, Onder G, Cesari M, Barillaro C, Lattanzio F, Carbonin PU, Bernabei R, SILVERNERT, HC Study Group (2004) Comorbidity and social factors predicted hospitalization in frail elderly patients. J Clin Epidemiol 57:832-836
50. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Herbert L, Newhouse JP, Weiler PC, Hiatt H (1991) The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 324:377-384
51. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED (2001) Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286:708-713
52. Leipzig RM (1998) Avoiding adverse drug effects in elderly patients. Clev Clin J Med 65:479-485
53. Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and fall in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 47:40-50
54. Lenaghan E, Holland R, Brooks A (2007) Home-based medication review in a high risk elderly population in primary care - the POLYMED randomised controlled trial. Age Ageing 36:292-297
55. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130:461-470
56. Manesse CK, Derkx FHM, de Ridder MAJ, Man in't Veld AJ, van der Cammen, TJM (1997) Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional survey. BMJ 315:1057-1058
57. McCall WV (2004) Sleep in the elderly: Burden, diagnosis, and treatment. Prim Care Companion J Clin Psychiatry 6:9-20
58. McCusker J, Cole MG, Dendukuri N, Belzile E (2003) Does delirium increase hospital stay? J Am Geriatr Soc 51:1539-1546
59. Monette J, Gurwitz JH, Avorn J (1995) Epidemiology of adverse drug events in the nursing home setting. Drugs Aging 7:203-211
60. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH for the National Kidney Disease Education Program Laboratory Working Group (2006) Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 51:5-18
61. Nakamura H, Tanaka E, Ishikawa A, Fukao K, Tsuji K, Ohkawa H (1998) Age-related changes in hepatic drugoxidizing activity using trimethadione as a probe drug. Hepatology Research 12:85-92
62. Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G (1996) Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol 49:255-259
63. Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, Matsuse H, Kinoshita M, Kohno S (2003) Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther 73:468-474
64. Palareti G, Legnani C (1996) Warfarin withdrawal - Pharmacokinetic- pharmacodynamic considerations. Clin Pharmacokinet 30:300-313
65. Pirmohamed M, Atuah KN (2006) Pharmacogenetics and adverse drug reactions. In: Lee A (Ed) Adverse Drug Reactions, Pharmaceutical Press, London
66. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329:15-19
67. Pirmohamed M, Park BK (2003) Cytochrom P450 enzyme polymorphisms and adverse drug reactions. Toxicology 192:23-32
68. Podrazik PM, Schwartz JB (1999) Cardiovascular pharmacology of aging. Cardiol Clin 17:17-34
69. Prince BS, Goetz CM, Rihn TL, Olsky M (1992) Drug-related emergency department visits and hospital admission. Am J Hosp Pharm 49:1696-1700
70. Quillen DA (1999) Common causes of vision loss in elderly patients. Am Fam Physician 60:99-108
71. Räihä I, Luutonen S, Piha J, Seppänen A, Toikka T, Sourander L (1995) Prevalence, predisposing factors, and prognostic importance of postural hypotension. Arch Intern Med 155:930-935
72. Ranganathan VK, Siemionow V, Sahgal V, Yue, GH (2001) Effects of aging on hand function. J Am Geriatr Soc 49:1478-1484
73. Rivers PH (1992) Compliance aids - do they work? Drugs Aging 2:103-111
74. Rochon PA, Gurwitz JH (1997) Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315:1096-1099
75. Rosholm JU, Nybo H, Ranberg KA, Himmelstrup B, Skjelbo E, Christensen K, Gram LF (2002) Hyponatraemia in very old nonhospitalized people. Drugs Aging 19:685-693
76. Rothwell PM (2005) External validity of randomized controlled trials: "To whom do the results of this trial apply?" Lancet 365:82-93
77. Saravay SM, Kaplowitz M, Kurek J, Zeman D, Pollack S, Novik S, Knowlton S, Brendel M, Hoffman L (2004) How do delirium and dementia increase length of stay of elderly general medical inpatients? Psychosomatics 45:235-242
78. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling AK, Avorn J (2002) Admissions by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 58:285-291
79. Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Youngs EJ (1999) The influence of age on propofol pharamcodynamcis. Anesthesiology 90:1502-1516
80. Schor JD (1992) Risk factors for delirium in hospitalised elderly. JAMA 267:827-831
81. Scott JC, Stanski DR (1987) Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 240:159-168
82. th edition. Hudson, Lexi Comp
83. Shock NW, Greulich RC, Andres R, Arenberg D, Costa PT Jr, Tobin JD (1984) Normal human aging. The Baltimore Longitudinal Study, NIH Publication No. 84-2450. http://www.grc.nia.nih.gov/blsahistory/publications.htm
84. Spagnoli A, Ostino G, Borga AD, D'Ambrosio R, Maggiorotti P, Todisco E, Prattichizzo W, Pia L, Comelli M (1989) Drug compliance and unreprorted drugs in the elderly. J Am Geriatr Soc 37:619-624
85. Spilker B (1991) Methods of assessing and improving patient compliance in clinical trials. In: Cramer, JA, Spilker, B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, pp 37-56
86. Steinhagen-Thiessen E, Borchelt M (2001) Morbidity, medication, and functional limitations in very old age. In: The Berlin Aging Study, aging from 70 to 100. Cambridge, Cambridge University Press
87. Stuck A, Kharicha K, Dapp U, Anders J, von Renteln-Kruse W, Meier- Baumgartner HP, Harari D, Swift CG, Ivanova K, Egger M, Gillmann G, Higa J, Beck JC, Iliffe S (2007) Developement, feasibility and performance of a health risk appraisal questionnaire for older persons. BMC Medical Research Methodology 7:1
88. Thomas EJ, Brennan TA (2000) Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ 320:741-744
89. Tune LE (2001) Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 62 (Suppl 21):11-14
90. Turnheim, K (1998) Drug dosage in the elderly. Is it rational? Drugs Aging 13:357-379
91. Van der Pols JC, Bates CJ, Thompson JR, Reacher M, Prentice A, Finch S (2000) Visual acuity measurements in a national sample of British elderly people. Br J Ophthalmol 84:165-170
92. WHO (1992) Interntional monitoring of adverse reactions to drugs: adverse reaction terminology. WHO Collaborating Center for International Drug Monitoring, Uppsala, Sweden
93. Widiger TA, Seidlitz L (2002) Personality, psychopathology, and aging. J Res Pers 36:335-362
94. Wood KL, on behalf of the MEDDRA Working Party (1994) The medical dictionary for drug regulatory affairs (MEDDRA). Pharmacoepidemiol Drug Saf 3:7-13
95. Zeeh J, Platt D (2002) The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 48:121-127